Submitted by Anonymous (not verified) on 28 May 2025 - 17:55
Human medicines European public assessment report (EPAR): NovoRapid, insulin aspart, Date of authorisation: 07/09/1999, Revision: 34, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): NovoRapid, insulin aspart, Date of authorisation: 07/09/1999, Revision: 34, Status: Authorised